Update on PI3K inhibitors for CLL: Idelalisib, copanlisib, duvelisib, and umbralisib - 100004

Spotlight
Video

Update on PI3K inhibitors for CLL: Idelalisib, copanlisib, duvelisib, and umbralisib

imedex has 1284 videos Subscribe Here

Loading........
Description: Earn CME: https://naccme.com/program/...

In this presentation from the 'Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice’ symposium, Dr. Jennifer R. Brown provides an update on PI3K inhibitors for CLL.

© 2018 Imedex, an HMP Company
Shared By : imedex
Posted on : 11/28/18
Added : 11 days ago